Pulmonary tuberculosis in dermatological patients on high-dose, long-term steroid therapy
Keywords:
Pulmonary tuberculosis, steroids, high-dose, long-termAbstract
Tuberculosis is a chronic and serious infection if left untreated. Currently one third of the world population is infected with this bacillus. The immunosuppression due to glucocorticoids in patients with skin diseases may cause acquisition of primary tuberculosis and the reactivation of nonactive tuberculosis. This review focuses on risk involved, diagnosis and treatment in such patients.References
Raviglione MC, O'Brien RJ. Tuberculosis. In: Kasper DL, Braunwald E, Fauci AS et al., eds. Harrison's Principles of Internal Medicine, 16th ed. London: McGraw-Hill Professional; 2005. P. 953-66.
World Health Organization. Tuberculosis Fact sheet No. 104 - Global and regional incidence. Revised November 2010. Cited online on 10.12.2014. URL:http://www.who.int/mediacentre/ factsheets/fs104/en/index.html.
Global tuberculosis control WHO report 2012. World Health Organization WHO/HTM/TB/2012.7. Cited online on 10.12.2013.
URL:http://www.who.int/entity/tb/publications/global_report/2010/pdf/full.pdf
Crompton GK, Haslett C, Chilvers ER. Immunological factors in disease. In: Haslett C, Chilvers ER, John Aet al., eds. Davidson’s Principles and Practice of Medicine, 20th ed. London: Churchill Livingstone; 2006. P. 75.
Kumar P, Clark M, editors. Clinical Medicine, 6th edn. London: WB Saunders; 2007.
Chan YC, Yosipovitch G. Suggested guidelines for screening and management of tuberculosis in patients taking oral glucocorticoids - an important but often neglected issue. J Am Acad Dermatol. 2003;49:91-5.
History of tuberculosis. URL:http://en.wikipedia.org/wiki/History of tuberculosis. Cited online on 10.12.2013.
Crompton GK, Haslett C, Chilvers ER. Diseases of the respiratory system. In: Haslett C, Chilvers ER, John A et al., editors. Davidson’s Principles and Practice of Medicine, 20th ed. Churchill Livingstone 2006: Page 695-703.
Tuberculosis. URL:http://en.wikipedia.org/wiki/Tuberculosis. Cited online on 10.12.2014.
World Health Organization 2010/2011 Tuberculosis Global Facts. Cited online on 10.12.2013. URL: http://www.who.int/entity/tb/ publications/global_report/2007/pdf/full.pdf
World Health Organization. Tuberculosis Fact sheet N°104 - Global and regional incidence. Revised March 2007. Cited online on 10.12.2012. URL: http://www.who.int/mediacentre/factsheets/ fs104/en/index.html
World Health Organization. Tuberculosis Profile Pakistan. Cited online on 10.12.2013. URL:http://www.who.int/mediacentre/ factsheets/fs104/en/index.html
Treatment of Tuberculosis. Guidelines for National Programmes. World Health Organization WHO/CDS/TB 2003.313. Cited online on 10.12.2014.
Ayieko J, Abuogi L, Simchowitz B et al. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014;14:91-.
Mitsos L, Sasseville D. Systemic corticosteroid use in dermatology: defining, detailing, and demystifying. Dermatol Rounds. 2012;7-2. Available from: http://www.dermatologyrounds.ca/cgi-bin/templates/body/archives.cfm?displaySectionID=906
Pal D, Behera D, Gupta D, Aggarwal A. Tuberculosis in patients receiving prolonged treatment with oral corticosteroids for respiratory disorders. Indian J Tub. 2002;49:83.
Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheumat. 2006;55:19-26.
Sayarlioglu M, Inanc M, Kamali S et al. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extra pulmonary localization. Lupus. 2004;13:274-8.
Sasaki Y, Yamagishi F, Yagi T et al. A clinical study in the collagen disease patients developed pulmonary tuberculosis during corticosteroid administration. Kekkaku. 2000;75:569-73.
Chogle AR, Sulakhe R. Concerns regarding use of immunosuppressive therapies without prior screening for latent tuberculosis in a case of systemic lupus erythematosus presenting with sensorineural deafness. J Assoc Physicians India. 2013;61:215-
Kobashi Y, Yoneyama H, Okimoto N et al. Clinical analysis of pulmonary tuberculosis in association with corticosteroid therapy. Kekkaku 1999; 74: 789-95.
Isabelle M, Eric H, Patrick C et al. Opportunistic infections in polymyositis and dermatomysitis. Arthritis Care & Research: 2005; 53: 155-165.
ATS, CDC, and Infectious Diseases Society of America. Treatment of tuberculosis. MMWR 2003; 52 (No. RR-11). http://www.cdc.gov/mmwr/PDF/rr/rr5211.pdf
American Thoracic Society (ATS) and CDC. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000;161. http://ajrccm.atsjournals.org/cgi/content/
Butt G, Asad F, Khurshid K, Pal SS. Frequency of pulmonary tuberculosis in patients with skin diseases requiring high dose long-term systemic steroid therapy. J Pak Assoc Dermatol. 2013;23:126-32.
Shim TS. Diagnosis and treatment of latent tuberculosis infection due to initiation of anti-TNF therapy. Tuberc Respir Dis. 2014;76:261-8.
